• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

小儿氨氯地平混悬液的生物利用度。

Bioavailability of a pediatric amlodipine suspension.

作者信息

Lyszkiewicz Dorothy A, Levichek Zina, Kozer Eran, Yagev Yaron, Moretti Myla, Hard Marjie, Koren Gideon

机构信息

Division of Clinical Pharmacology and Toxicology, Hospital for Sick Children, 555 University Avenue, Toronto, Ontario, Canada.

出版信息

Pediatr Nephrol. 2003 Jul;18(7):675-8. doi: 10.1007/s00467-003-1088-2. Epub 2003 May 7.

DOI:10.1007/s00467-003-1088-2
PMID:12734745
Abstract

Currently, a suspension of crushed tablets of amlodidpine is widely used in children with hypertension without knowledge of its bioavailability. A comparative bioavailability study of a tablet and suspension formulation of amlodipine was completed in 20 healthy adult volunteers. Bioequivalence of the suspension was not different from the tablets. These results support the use of the suspension in children who cannot take the tablet.

摘要

目前,氨氯地平压碎片的混悬液在不明其生物利用度的情况下被广泛用于高血压儿童。一项针对氨氯地平片剂和混悬液制剂的比较生物利用度研究在20名健康成年志愿者中完成。该混悬液的生物等效性与片剂无异。这些结果支持在无法服用片剂的儿童中使用该混悬液。

相似文献

1
Bioavailability of a pediatric amlodipine suspension.小儿氨氯地平混悬液的生物利用度。
Pediatr Nephrol. 2003 Jul;18(7):675-8. doi: 10.1007/s00467-003-1088-2. Epub 2003 May 7.
2
Bioequivalence study of an extemporaneously prepared oral solution of amlodipine suitable for use in pediatric patients compared to commercial tablets.
Int J Clin Pharmacol Ther. 2016 Jan;54(1):65-72. doi: 10.5414/CP202449.
3
Comparative bioavailability cf two amlodipine formulation in healthy volunteers.健康志愿者中两种氨氯地平制剂的相对生物利用度。 你提供的原文中“cf”可能有误,正确的可能是“of” 。
Arzneimittelforschung. 2007;57(7):467-71.
4
Pharmacokinetics and bioequivalence study of a generic amlodipine tablet formulation in healthy male volunteers.一种通用型氨氯地平片剂制剂在健康男性志愿者中的药代动力学和生物等效性研究。
Arzneimittelforschung. 2007;57(7):462-6. doi: 10.1055/s-0031-1296632.
5
Amlodipine bioequivalence achieved with a very sensitive liquid chromatography tandem mass spectrometric bioassay.通过一种非常灵敏的液相色谱串联质谱生物测定法实现了氨氯地平的生物等效性。
Arzneimittelforschung. 2000 Aug;50(8):688-94. doi: 10.1055/s-0031-1300274.
6
Bioavailability of amlodipine besylate/atorvastatin calcium combination tablet.苯磺酸氨氯地平/阿托伐他汀钙片的生物利用度。
J Clin Pharmacol. 2006 Sep;46(9):1030-7. doi: 10.1177/0091270006291031.
7
Bioavailability of amlodipine besylate following oral administration as a tablet dispersed in applesauce.苯磺酸氨氯地平以片剂形式分散于苹果酱中口服后的生物利用度。
J Clin Pharmacol. 2005 Jun;45(6):695-8. doi: 10.1177/0091270005276203.
8
Limited-sampling strategy models for estimating the area under the plasma concentration-time curve for amlodipine.
Eur J Clin Pharmacol. 1999 Nov;55(9):651-7. doi: 10.1007/s002280050688.
9
Comparative pharmacokinetics of a single oral dose of two formulations of amlodipine. A randomized, single-blind, two-period, two-sequence, crossover study.氨氯地平两种制剂单次口服给药的比较药代动力学。一项随机、单盲、两期、双序列、交叉研究。
Arzneimittelforschung. 2008;58(7):323-7. doi: 10.1055/s-0031-1296514.
10
Pharmacokinetics of amlodipine and olmesartan after administration of amlodipine besylate and olmesartan medoxomil in separate dosage forms and as a fixed-dose combination.苯磺酸氨氯地平和奥美沙坦酯分别以不同剂型给药以及作为固定剂量复方制剂给药后的氨氯地平和奥美沙坦的药代动力学。
J Clin Pharmacol. 2008 Nov;48(11):1309-22. doi: 10.1177/0091270008322176.

引用本文的文献

1
Extemporaneous Compounding and Physiological Modeling of Amlodipine/Valsartan Suspension.氨氯地平/缬沙坦混悬液的临时调配与生理模型构建
Int J Hypertens. 2021 Mar 12;2021:6695744. doi: 10.1155/2021/6695744. eCollection 2021.
2
Formulations of Amlodipine: A Review.氨氯地平制剂:综述
J Pharm (Cairo). 2016;2016:8961621. doi: 10.1155/2016/8961621. Epub 2016 Oct 16.
3
Formulations for children: problems and solutions.儿童用药配方:问题与解决方案。

本文引用的文献

1
Pharmacokinetic assessment of an oral enalapril suspension for use in children.用于儿童的口服依那普利混悬液的药代动力学评估。
Biopharm Drug Dispos. 2000 Dec;21(9):339-44. doi: 10.1002/bdd.241.
2
Antihypertensive efficacy of amlodipine in children with chronic kidney diseases.
J Hum Hypertens. 2001 Jun;15(6):387-91. doi: 10.1038/sj.jhh.1001203.
3
United States Food and Drug Administration requirements for approval of generic drug products.美国食品药品监督管理局对仿制药产品批准的要求。
Br J Clin Pharmacol. 2015 Mar;79(3):405-18. doi: 10.1111/bcp.12268.
4
Bioequivalence of dispersed stavudine: opened versus closed capsule dosing.散剂司他夫定的生物等效性:胶囊打开与闭合给药对比。
Antivir Ther. 2011;16(7):1131-4. doi: 10.3851/IMP1876.
5
Superior palatability of crushed lercanidipine compared with amlodipine among children.压碎的乐卡地平比氨氯地平更受儿童欢迎。
Br J Clin Pharmacol. 2010 Feb;69(2):204-6. doi: 10.1111/j.1365-2125.2009.03580.x.
J Clin Psychiatry. 2001;62 Suppl 5:4-9; discussion 23-4.
4
A randomized prospective crossover trial of amlodipine in pediatric hypertension.氨氯地平治疗儿童高血压的随机前瞻性交叉试验。
Pediatr Nephrol. 2000 Oct;14(12):1083-7. doi: 10.1007/s004670000400.
5
Treatment of hypertensive children with amlodipine.氨氯地平治疗高血压儿童。
Am J Hypertens. 2000 Oct;13(10):1061-6. doi: 10.1016/s0895-7061(00)00278-8.
6
Treatment of pediatric hypertension.
Pharmacotherapy. 2000 Feb;20(2):140-50. doi: 10.1592/phco.20.3.140.34782.
7
Use of calcium-channel blockers in pediatric renal transplant recipients.钙通道阻滞剂在小儿肾移植受者中的应用。
Pediatr Transplant. 1999 Nov;3(4):288-92. doi: 10.1034/j.1399-3046.1999.00056.x.
8
Efficacy of amlodipine in pediatric patients with hypertension.
Pediatr Nephrol. 1999 May;13(4):304-10. doi: 10.1007/s004670050614.
9
Stability of amlodipine besylate in two liquid dosage forms.苯磺酸氨氯地平在两种液体制剂中的稳定性。
J Am Pharm Assoc (Wash). 1999 May-Jun;39(3):375-7. doi: 10.1016/s1086-5802(16)30454-5.
10
Amlodipine once-daily in systemic hypertension.
Eur J Pediatr. 1998 Aug;157(8):618-21. doi: 10.1007/s004310050897.